Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doreen A Ezeife

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Review of Respiratory Medicine|December 1, 2017
Personalized medicine for non-small cell lung cancer: where are we now and where can we go?Doreen A Ezeife, Natasha B Leighl
Cancer|June 17, 2015
Reply to discrepancies in drug approvals: A global dilemmaDoreen A Ezeife, Tony H Truong, Patricia A Tang
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 9, 2023
Doreen A Ezeife, Greg Padmore, Marcus Vaska, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 24, 2022
Ensuring equitable access to cancer care for Black patients in CanadaDoreen A Ezeife, Greg Padmore, Marcus Vaska, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2021
An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on AccessNatasha B Leighl, Sharon Nirmalakumar, Doreen A Ezeife, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Effect of Race and Ethnicity on Academic Achievements in Cancer Physicians and ScientistsDoreen A Ezeife, Amanda Khan, Mark Melika-Abusefien, et al.
Cancer|January 22, 2015
Comparison of oncology drug approval between Health Canada and the US Food and Drug AdministrationDoreen A Ezeife, Tony H Truong, Daniel Y C Heng, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Impact of Oncology Drug Review Times on Public Funding RecommendationsMarya Hussain, Chelsea Wong, Eddy Taguedong, et al.
American Journal of Clinical Oncology|December 17, 2019
Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung CancerAnifat A Elegbede, Amanda J Gibson, Hao Fu, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare SystemMaisam Makarem, Doreen A Ezeife, Adam C Smith, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Review of Respiratory Medicine|December 1, 2017
Personalized medicine for non-small cell lung cancer: where are we now and where can we go?Doreen A Ezeife, Natasha B Leighl
Cancer|June 17, 2015
Reply to discrepancies in drug approvals: A global dilemmaDoreen A Ezeife, Tony H Truong, Patricia A Tang
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 9, 2023
Doreen A Ezeife, Greg Padmore, Marcus Vaska, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 24, 2022
Ensuring equitable access to cancer care for Black patients in CanadaDoreen A Ezeife, Greg Padmore, Marcus Vaska, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2021
An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on AccessNatasha B Leighl, Sharon Nirmalakumar, Doreen A Ezeife, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Effect of Race and Ethnicity on Academic Achievements in Cancer Physicians and ScientistsDoreen A Ezeife, Amanda Khan, Mark Melika-Abusefien, et al.
Cancer|January 22, 2015
Comparison of oncology drug approval between Health Canada and the US Food and Drug AdministrationDoreen A Ezeife, Tony H Truong, Daniel Y C Heng, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Impact of Oncology Drug Review Times on Public Funding RecommendationsMarya Hussain, Chelsea Wong, Eddy Taguedong, et al.
American Journal of Clinical Oncology|December 17, 2019
Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung CancerAnifat A Elegbede, Amanda J Gibson, Hao Fu, et al.
Current Oncology (Toronto, Ont.)|August 27, 2021
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare SystemMaisam Makarem, Doreen A Ezeife, Adam C Smith, et al.
Pageof 2